

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 5.11174025 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 5.11174025 |
| 3 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.94762616 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 4.84583310 |
| 5 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.79176593 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.68952202 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.68952202 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 4.68952202 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.68952202 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.68952202 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.68952202 |
| 12 | response to peptidoglycan (GO:0032494) | 4.63969417 |
| 13 | neutrophil mediated immunity (GO:0002446) | 4.43326042 |
| 14 | muscle filament sliding (GO:0030049) | 4.38955907 |
| 15 | actin-myosin filament sliding (GO:0033275) | 4.38955907 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 4.31246160 |
| 17 | detection of molecule of bacterial origin (GO:0032490) | 4.30800756 |
| 18 | negative regulation of interleukin-12 production (GO:0032695) | 4.29059920 |
| 19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.08569482 |
| 20 | negative regulation of cell killing (GO:0031342) | 4.08569482 |
| 21 | regulation of cell communication by electrical coupling (GO:0010649) | 3.97180054 |
| 22 | skeletal muscle contraction (GO:0003009) | 3.96885256 |
| 23 | microglial cell activation (GO:0001774) | 3.96865860 |
| 24 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.92290806 |
| 25 | respiratory burst (GO:0045730) | 3.90961440 |
| 26 | neuronal action potential propagation (GO:0019227) | 3.90188476 |
| 27 | myeloid leukocyte mediated immunity (GO:0002444) | 3.88976603 |
| 28 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.78333607 |
| 29 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.77710574 |
| 30 | neutrophil activation (GO:0042119) | 3.76740353 |
| 31 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.75498193 |
| 32 | presynaptic membrane organization (GO:0097090) | 3.74900563 |
| 33 | synaptic vesicle maturation (GO:0016188) | 3.66127965 |
| 34 | regulation of skeletal muscle contraction (GO:0014819) | 3.62655541 |
| 35 | detection of other organism (GO:0098543) | 3.62286714 |
| 36 | response to pheromone (GO:0019236) | 3.60441890 |
| 37 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.58553127 |
| 38 | neuron cell-cell adhesion (GO:0007158) | 3.57022511 |
| 39 | actin-mediated cell contraction (GO:0070252) | 3.51326262 |
| 40 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.49887671 |
| 41 | granulocyte activation (GO:0036230) | 3.47675370 |
| 42 | macrophage activation (GO:0042116) | 3.47482061 |
| 43 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.45452418 |
| 44 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.42363415 |
| 45 | dendritic spine morphogenesis (GO:0060997) | 3.42129177 |
| 46 | presynaptic membrane assembly (GO:0097105) | 3.42098068 |
| 47 | establishment of mitochondrion localization (GO:0051654) | 3.37243394 |
| 48 | cranial nerve morphogenesis (GO:0021602) | 3.36860910 |
| 49 | neuron recognition (GO:0008038) | 3.34939574 |
| 50 | negative regulation of protein localization to cell surface (GO:2000009) | 3.34211659 |
| 51 | detection of external biotic stimulus (GO:0098581) | 3.33951640 |
| 52 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.31622745 |
| 53 | axonal fasciculation (GO:0007413) | 3.30623361 |
| 54 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.29174172 |
| 55 | neuromuscular synaptic transmission (GO:0007274) | 3.25036511 |
| 56 | response to host immune response (GO:0052572) | 3.22431097 |
| 57 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.22431097 |
| 58 | postsynaptic membrane organization (GO:0001941) | 3.21422129 |
| 59 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.19895108 |
| 60 | neural tube formation (GO:0001841) | 3.18818896 |
| 61 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.17658775 |
| 62 | cell migration in hindbrain (GO:0021535) | 3.17587208 |
| 63 | cellular extravasation (GO:0045123) | 3.14883432 |
| 64 | dendrite morphogenesis (GO:0048813) | 3.14553912 |
| 65 | sequestering of actin monomers (GO:0042989) | 3.13556644 |
| 66 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.13433000 |
| 67 | regulation of synapse structural plasticity (GO:0051823) | 3.13159736 |
| 68 | layer formation in cerebral cortex (GO:0021819) | 3.12655361 |
| 69 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.12086623 |
| 70 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.05868014 |
| 71 | detection of biotic stimulus (GO:0009595) | 3.05379782 |
| 72 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.04083615 |
| 73 | detection of bacterium (GO:0016045) | 3.01685370 |
| 74 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.01110068 |
| 75 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.00228535 |
| 76 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.00228535 |
| 77 | negative regulation of axon extension (GO:0030517) | 2.99162959 |
| 78 | positive regulation of mitochondrial fission (GO:0090141) | 2.98612323 |
| 79 | immunoglobulin mediated immune response (GO:0016064) | 2.97775022 |
| 80 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.97716826 |
| 81 | skeletal muscle fiber development (GO:0048741) | 2.97458316 |
| 82 | protein localization to synapse (GO:0035418) | 2.96381239 |
| 83 | negative regulation of axonogenesis (GO:0050771) | 2.95491851 |
| 84 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.94704788 |
| 85 | negative regulation of T cell mediated immunity (GO:0002710) | 2.94153220 |
| 86 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.92997443 |
| 87 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.90332443 |
| 88 | skeletal muscle adaptation (GO:0043501) | 2.89392796 |
| 89 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.86217927 |
| 90 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 2.85548955 |
| 91 | regulation of interferon-alpha production (GO:0032647) | 2.85489461 |
| 92 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.84137514 |
| 93 | neuron fate determination (GO:0048664) | 2.83414503 |
| 94 | synaptic vesicle exocytosis (GO:0016079) | 2.83111624 |
| 95 | germinal center formation (GO:0002467) | 2.82980284 |
| 96 | response to inactivity (GO:0014854) | 2.81606856 |
| 97 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.79116922 |
| 98 | glutamate secretion (GO:0014047) | 2.78369644 |
| 99 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.77936409 |
| 100 | myeloid cell activation involved in immune response (GO:0002275) | 2.77338273 |
| 101 | actin filament-based movement (GO:0030048) | 2.77212768 |
| 102 | regulation of collateral sprouting (GO:0048670) | 2.75708606 |
| 103 | negative regulation of interleukin-1 production (GO:0032692) | 2.75215882 |
| 104 | purine nucleotide salvage (GO:0032261) | 2.75160278 |
| 105 | sarcomere organization (GO:0045214) | 2.74333648 |
| 106 | positive regulation of interferon-alpha production (GO:0032727) | 2.72146523 |
| 107 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.71479254 |
| 108 | regulation of mast cell activation (GO:0033003) | 2.70800023 |
| 109 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.70169899 |
| 110 | myelination (GO:0042552) | 2.69984589 |
| 111 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.69757556 |
| 112 | activated T cell proliferation (GO:0050798) | 2.69408276 |
| 113 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.69148026 |
| 114 | ensheathment of neurons (GO:0007272) | 2.68770716 |
| 115 | axon ensheathment (GO:0008366) | 2.68770716 |
| 116 | cerebellar granule cell differentiation (GO:0021707) | 2.68213980 |
| 117 | positive regulation of mast cell activation (GO:0033005) | 2.68209083 |
| 118 | myofibril assembly (GO:0030239) | 2.67102636 |
| 119 | leukocyte aggregation (GO:0070486) | 2.66884412 |
| 120 | regulation of relaxation of muscle (GO:1901077) | 2.66590190 |
| 121 | locomotory exploration behavior (GO:0035641) | 2.65097019 |
| 122 | plasma membrane repair (GO:0001778) | 2.64073265 |
| 123 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.61592395 |
| 124 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.61418573 |
| 125 | negative regulation of microtubule polymerization (GO:0031115) | 2.61413678 |
| 126 | positive regulation of interleukin-6 production (GO:0032755) | 2.61238357 |
| 127 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.60414838 |
| 128 | response to host (GO:0075136) | 2.60189860 |
| 129 | response to host defenses (GO:0052200) | 2.60189860 |
| 130 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.60189860 |
| 131 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.60005923 |
| 132 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.59275688 |
| 133 | regulation of glutamate secretion (GO:0014048) | 2.58978479 |
| 134 | neuronal ion channel clustering (GO:0045161) | 2.58464625 |
| 135 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.57213028 |
| 136 | striated muscle contraction (GO:0006941) | 2.56939899 |
| 137 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.56801858 |
| 138 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.56724233 |
| 139 | negative regulation of necroptotic process (GO:0060546) | 2.56457185 |
| 140 | auditory behavior (GO:0031223) | 2.56452341 |
| 141 | mitochondrion transport along microtubule (GO:0047497) | 2.56324271 |
| 142 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.56324271 |
| 143 | vocalization behavior (GO:0071625) | 2.56171315 |
| 144 | regulation of fever generation (GO:0031620) | 2.55562811 |
| 145 | positive regulation of interferon-beta production (GO:0032728) | 2.54223355 |
| 146 | positive regulation of interleukin-17 production (GO:0032740) | 2.53879922 |
| 147 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.53241891 |
| 148 | myotube cell development (GO:0014904) | 2.53026810 |
| 149 | regulation of necroptotic process (GO:0060544) | 2.52539469 |
| 150 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.52215359 |
| 151 | central nervous system neuron axonogenesis (GO:0021955) | 2.51956003 |
| 152 | regulation of interleukin-17 production (GO:0032660) | 2.51613349 |
| 153 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.51457188 |
| 154 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.51419068 |
| 155 | positive regulation of synapse assembly (GO:0051965) | 2.51024388 |
| 156 | interferon-gamma production (GO:0032609) | 2.50978899 |
| 157 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.50159835 |
| 158 | neutrophil chemotaxis (GO:0030593) | 2.49812735 |
| 159 | negative regulation of neurotransmitter transport (GO:0051589) | 2.49232542 |
| 160 | regulation of respiratory system process (GO:0044065) | 2.49146926 |
| 161 | eye photoreceptor cell differentiation (GO:0001754) | 2.48379318 |
| 162 | photoreceptor cell differentiation (GO:0046530) | 2.48379318 |
| 163 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.47869440 |
| 164 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.47869440 |
| 165 | purine-containing compound salvage (GO:0043101) | 2.47764963 |
| 166 | cytokine secretion (GO:0050663) | 2.47630661 |
| 167 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.47582538 |
| 168 | regulation of synapse assembly (GO:0051963) | 2.47095913 |
| 169 | B cell mediated immunity (GO:0019724) | 2.45360685 |
| 170 | myotube differentiation (GO:0014902) | 2.45314649 |
| 171 | phagosome maturation (GO:0090382) | 2.44914043 |
| 172 | leukocyte mediated cytotoxicity (GO:0001909) | 2.44774160 |
| 173 | positive regulation of type 2 immune response (GO:0002830) | 2.43678667 |
| 174 | adult walking behavior (GO:0007628) | 2.43324146 |
| 175 | neutrophil migration (GO:1990266) | 2.43238138 |
| 176 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.42725293 |
| 177 | defense response to protozoan (GO:0042832) | 2.42481341 |
| 178 | limb bud formation (GO:0060174) | 2.42265378 |
| 179 | dendritic spine organization (GO:0097061) | 2.41810217 |
| 180 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.40941530 |
| 181 | nerve growth factor signaling pathway (GO:0038180) | 2.39233636 |
| 182 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.38922069 |
| 183 | muscle cell cellular homeostasis (GO:0046716) | 2.37894041 |
| 184 | regulation of extent of cell growth (GO:0061387) | 2.37086624 |
| 185 | mechanosensory behavior (GO:0007638) | 2.36403849 |
| 186 | substantia nigra development (GO:0021762) | 2.36179602 |
| 187 | creatine metabolic process (GO:0006600) | 2.35842332 |
| 188 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.35560865 |
| 189 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.35547210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.10415225 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.78831888 |
| 3 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.15348361 |
| 4 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 3.02302555 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.93922881 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.83323350 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.83323350 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.82565396 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.80628614 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.66659408 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.61602905 |
| 12 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.50681117 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.49374199 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.48021838 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.39665091 |
| 16 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.39402621 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.37803397 |
| 18 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.31808148 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.29369814 |
| 20 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.29301327 |
| 21 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.25462863 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.20445890 |
| 23 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.18537189 |
| 24 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.14061815 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.02854777 |
| 26 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.02762085 |
| 27 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.02125492 |
| 28 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.01884225 |
| 29 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.98737201 |
| 30 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.97837801 |
| 31 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.95932444 |
| 32 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.91195574 |
| 33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.90362892 |
| 34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.87354163 |
| 35 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.86125259 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.81946178 |
| 37 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.79779245 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.77819493 |
| 39 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.77322761 |
| 40 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.75202194 |
| 41 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.72198803 |
| 42 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.71488099 |
| 43 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.69353623 |
| 44 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.66828966 |
| 45 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.64398905 |
| 46 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.61847615 |
| 47 | EWS_26573619_Chip-Seq_HEK293_Human | 1.60206958 |
| 48 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.58729108 |
| 49 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.58314895 |
| 50 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.57883452 |
| 51 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.56621217 |
| 52 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.56404276 |
| 53 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.55774296 |
| 54 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.54660154 |
| 55 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.53199578 |
| 56 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.51050102 |
| 57 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.50362834 |
| 58 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.49322081 |
| 59 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.47550053 |
| 60 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.45802097 |
| 61 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.45491473 |
| 62 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.44867489 |
| 63 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44714436 |
| 64 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.43451313 |
| 65 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.38810216 |
| 66 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.36944435 |
| 67 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.35280290 |
| 68 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.35135774 |
| 69 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.35033867 |
| 70 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.34795352 |
| 71 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33953716 |
| 72 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.31044869 |
| 73 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.29064378 |
| 74 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.28422026 |
| 75 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28080572 |
| 76 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.27711141 |
| 77 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.25352097 |
| 78 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.24311870 |
| 79 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.24275325 |
| 80 | VDR_22108803_ChIP-Seq_LS180_Human | 1.22660045 |
| 81 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.22534433 |
| 82 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.21210991 |
| 83 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20098745 |
| 84 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.19490828 |
| 85 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.19394826 |
| 86 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.18377993 |
| 87 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.17046116 |
| 88 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.16836469 |
| 89 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.16720823 |
| 90 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.16546425 |
| 91 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.15499399 |
| 92 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.14638524 |
| 93 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.13268345 |
| 94 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.12301978 |
| 95 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.12285892 |
| 96 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11761231 |
| 97 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.11761231 |
| 98 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.11510168 |
| 99 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.11207378 |
| 100 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.11207378 |
| 101 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.10406111 |
| 102 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.09671540 |
| 103 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.09421011 |
| 104 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.09343954 |
| 105 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.08523335 |
| 106 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.07827103 |
| 107 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.07576900 |
| 108 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.06429227 |
| 109 | P300_19829295_ChIP-Seq_ESCs_Human | 1.06366143 |
| 110 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.06290516 |
| 111 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06192777 |
| 112 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05981540 |
| 113 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.05497582 |
| 114 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.05497582 |
| 115 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05478462 |
| 116 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.05368700 |
| 117 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.05278128 |
| 118 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04473152 |
| 119 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.03724013 |
| 120 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.03724013 |
| 121 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.03359790 |
| 122 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.03350983 |
| 123 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.03306512 |
| 124 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.02689484 |
| 125 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02488197 |
| 126 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.01948645 |
| 127 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.01883783 |
| 128 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.01559659 |
| 129 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.01018364 |
| 130 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.00935145 |
| 131 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.00209672 |
| 132 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.99515919 |
| 133 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.99136656 |
| 134 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.98925737 |
| 135 | MYB_26560356_Chip-Seq_TH2_Human | 0.98880257 |
| 136 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.98240687 |
| 137 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.97501263 |
| 138 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.97331423 |
| 139 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.96616220 |
| 140 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.96160539 |
| 141 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.96081442 |
| 142 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.96029347 |
| 143 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.95168569 |
| 144 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95130471 |
| 145 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.95078287 |
| 146 | AR_19668381_ChIP-Seq_PC3_Human | 0.94191878 |
| 147 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.93512519 |
| 148 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.92524823 |
| 149 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.92196220 |
| 150 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.91346358 |
| 151 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.91078697 |
| 152 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.91077647 |
| 153 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.89973517 |
| 154 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.89949000 |
| 155 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.89587668 |
| 156 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.89253196 |
| 157 | AR_25329375_ChIP-Seq_VCAP_Human | 0.88807949 |
| 158 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.87837459 |
| 159 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87097380 |
| 160 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86361225 |
| 161 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.84040604 |
| 162 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83206842 |
| 163 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.80802165 |
| 164 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.80695201 |
| 165 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.80103289 |
| 166 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.78117353 |
| 167 | STAT3_23295773_ChIP-Seq_U87_Human | 0.78016872 |
| 168 | FUS_26573619_Chip-Seq_HEK293_Human | 0.77959515 |
| 169 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.76984349 |
| 170 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.76464359 |
| 171 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.76389374 |
| 172 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.75822935 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.16177410 |
| 2 | MP0004145_abnormal_muscle_electrophysio | 4.50429053 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.73806708 |
| 4 | MP0003880_abnormal_central_pattern | 3.65839085 |
| 5 | MP0003303_peritoneal_inflammation | 3.57681897 |
| 6 | MP0003221_abnormal_cardiomyocyte_apopto | 3.44833404 |
| 7 | MP0004270_analgesia | 3.40773012 |
| 8 | MP0000751_myopathy | 3.11751036 |
| 9 | MP0000749_muscle_degeneration | 2.89347790 |
| 10 | MP0006082_CNS_inflammation | 2.72434577 |
| 11 | MP0009785_altered_susceptibility_to | 2.64167390 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.44947015 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.37150108 |
| 14 | MP0003646_muscle_fatigue | 2.34223000 |
| 15 | MP0003635_abnormal_synaptic_transmissio | 2.31456497 |
| 16 | MP0000747_muscle_weakness | 2.20662797 |
| 17 | MP0000778_abnormal_nervous_system | 2.19519283 |
| 18 | MP0009764_decreased_sensitivity_to | 2.14307119 |
| 19 | MP0003436_decreased_susceptibility_to | 2.13755024 |
| 20 | MP0002106_abnormal_muscle_physiology | 2.12678142 |
| 21 | MP0002419_abnormal_innate_immunity | 2.05246453 |
| 22 | MP0000759_abnormal_skeletal_muscle | 2.04640178 |
| 23 | MP0003828_pulmonary_edema | 1.96342105 |
| 24 | MP0005671_abnormal_response_to | 1.94936356 |
| 25 | MP0002734_abnormal_mechanical_nocicepti | 1.94325299 |
| 26 | MP0002063_abnormal_learning/memory/cond | 1.90464932 |
| 27 | MP0005369_muscle_phenotype | 1.85961494 |
| 28 | MP0005025_abnormal_response_to | 1.79381560 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.76252875 |
| 30 | MP0002064_seizures | 1.75223531 |
| 31 | MP0009278_abnormal_bone_marrow | 1.72478708 |
| 32 | MP0009745_abnormal_behavioral_response | 1.72304920 |
| 33 | MP0001486_abnormal_startle_reflex | 1.71451300 |
| 34 | MP0005000_abnormal_immune_tolerance | 1.69051853 |
| 35 | MP0004233_abnormal_muscle_weight | 1.66914442 |
| 36 | MP0005171_absent_coat_pigmentation | 1.66550384 |
| 37 | MP0002822_catalepsy | 1.66328129 |
| 38 | MP0004036_abnormal_muscle_relaxation | 1.65446203 |
| 39 | MP0000920_abnormal_myelination | 1.65311355 |
| 40 | MP0002272_abnormal_nervous_system | 1.63472712 |
| 41 | MP0004087_abnormal_muscle_fiber | 1.62454333 |
| 42 | MP0002132_abnormal_respiratory_system | 1.62355204 |
| 43 | MP0002184_abnormal_innervation | 1.61532180 |
| 44 | MP0003122_maternal_imprinting | 1.61510041 |
| 45 | MP0001800_abnormal_humoral_immune | 1.60057069 |
| 46 | MP0001968_abnormal_touch/_nociception | 1.56746746 |
| 47 | MP0005451_abnormal_body_composition | 1.56656722 |
| 48 | MP0000733_abnormal_muscle_development | 1.55856483 |
| 49 | MP0000343_altered_response_to | 1.55539221 |
| 50 | MP0005167_abnormal_blood-brain_barrier | 1.54904630 |
| 51 | MP0002723_abnormal_immune_serum | 1.54760072 |
| 52 | MP0008569_lethality_at_weaning | 1.52048046 |
| 53 | MP0002735_abnormal_chemical_nociception | 1.50423742 |
| 54 | MP0008260_abnormal_autophagy | 1.50360959 |
| 55 | MP0005620_abnormal_muscle_contractility | 1.49480757 |
| 56 | MP0002452_abnormal_antigen_presenting | 1.49143445 |
| 57 | MP0002837_dystrophic_cardiac_calcinosis | 1.48625886 |
| 58 | MP0002572_abnormal_emotion/affect_behav | 1.48453329 |
| 59 | MP0002277_abnormal_respiratory_mucosa | 1.47958293 |
| 60 | MP0000955_abnormal_spinal_cord | 1.47580595 |
| 61 | MP0001790_abnormal_immune_system | 1.44514615 |
| 62 | MP0005387_immune_system_phenotype | 1.44514615 |
| 63 | MP0005248_abnormal_Harderian_gland | 1.44007857 |
| 64 | MP0006276_abnormal_autonomic_nervous | 1.42913858 |
| 65 | MP0006054_spinal_hemorrhage | 1.41404662 |
| 66 | MP0002067_abnormal_sensory_capabilities | 1.41010358 |
| 67 | MP0004142_abnormal_muscle_tone | 1.39554912 |
| 68 | MP0003300_gastrointestinal_ulcer | 1.39386594 |
| 69 | MP0004883_abnormal_blood_vessel | 1.39077720 |
| 70 | MP0009046_muscle_twitch | 1.37752512 |
| 71 | MP0002653_abnormal_ependyma_morphology | 1.36983225 |
| 72 | MP0004742_abnormal_vestibular_system | 1.36527076 |
| 73 | MP0002420_abnormal_adaptive_immunity | 1.34689029 |
| 74 | MP0002733_abnormal_thermal_nociception | 1.34521911 |
| 75 | MP0000465_gastrointestinal_hemorrhage | 1.34448637 |
| 76 | MP0001819_abnormal_immune_cell | 1.34058468 |
| 77 | MP0002269_muscular_atrophy | 1.33783599 |
| 78 | MP0001970_abnormal_pain_threshold | 1.32935472 |
| 79 | MP0001299_abnormal_eye_distance/ | 1.32844324 |
| 80 | MP0004811_abnormal_neuron_physiology | 1.29464375 |
| 81 | MP0006036_abnormal_mitochondrial_physio | 1.29055608 |
| 82 | MP0009250_abnormal_appendicular_skeleto | 1.27436182 |
| 83 | MP0003656_abnormal_erythrocyte_physiolo | 1.26707590 |
| 84 | MP0005266_abnormal_metabolism | 1.26338847 |
| 85 | MP0002882_abnormal_neuron_morphology | 1.25661873 |
| 86 | MP0003137_abnormal_impulse_conducting | 1.25205625 |
| 87 | MP0005409_darkened_coat_color | 1.24758860 |
| 88 | MP0001440_abnormal_grooming_behavior | 1.24484509 |
| 89 | MP0000750_abnormal_muscle_regeneration | 1.23357878 |
| 90 | MP0001529_abnormal_vocalization | 1.21706459 |
| 91 | MP0000049_abnormal_middle_ear | 1.17753584 |
| 92 | MP0003806_abnormal_nucleotide_metabolis | 1.17540486 |
| 93 | MP0004130_abnormal_muscle_cell | 1.15833355 |
| 94 | MP0002557_abnormal_social/conspecific_i | 1.14113239 |
| 95 | MP0006035_abnormal_mitochondrial_morpho | 1.13859826 |
| 96 | MP0005084_abnormal_gallbladder_morpholo | 1.13576900 |
| 97 | MP0001905_abnormal_dopamine_level | 1.12746050 |
| 98 | MP0002066_abnormal_motor_capabilities/c | 1.12553852 |
| 99 | MP0002736_abnormal_nociception_after | 1.11451510 |
| 100 | MP0010030_abnormal_orbit_morphology | 1.11433250 |
| 101 | MP0001845_abnormal_inflammatory_respons | 1.08248535 |
| 102 | MP0002108_abnormal_muscle_morphology | 1.06407192 |
| 103 | MP0001533_abnormal_skeleton_physiology | 1.06296001 |
| 104 | MP0004484_altered_response_of | 1.04890766 |
| 105 | MP0004924_abnormal_behavior | 1.04756775 |
| 106 | MP0005386_behavior/neurological_phenoty | 1.04756775 |
| 107 | MP0001545_abnormal_hematopoietic_system | 1.04275925 |
| 108 | MP0005397_hematopoietic_system_phenotyp | 1.04275925 |
| 109 | MP0004858_abnormal_nervous_system | 1.02802534 |
| 110 | MP0002938_white_spotting | 1.02744071 |
| 111 | MP0004134_abnormal_chest_morphology | 1.02205714 |
| 112 | MP0004885_abnormal_endolymph | 0.99040553 |
| 113 | MP0002751_abnormal_autonomic_nervous | 0.98902790 |
| 114 | MP0002405_respiratory_system_inflammati | 0.98769247 |
| 115 | MP0003385_abnormal_body_wall | 0.97760539 |
| 116 | MP0002234_abnormal_pharynx_morphology | 0.97497849 |
| 117 | MP0008469_abnormal_protein_level | 0.97383530 |
| 118 | MP0002152_abnormal_brain_morphology | 0.97372722 |
| 119 | MP0001188_hyperpigmentation | 0.96998895 |
| 120 | MP0005083_abnormal_biliary_tract | 0.95045637 |
| 121 | MP0002752_abnormal_somatic_nervous | 0.94765518 |
| 122 | MP0001502_abnormal_circadian_rhythm | 0.94583903 |
| 123 | MP0000716_abnormal_immune_system | 0.93464196 |
| 124 | MP0000858_altered_metastatic_potential | 0.91214888 |
| 125 | MP0000631_abnormal_neuroendocrine_gland | 0.89608009 |
| 126 | MP0000685_abnormal_immune_system | 0.88930783 |
| 127 | MP0004084_abnormal_cardiac_muscle | 0.88572176 |
| 128 | MP0005376_homeostasis/metabolism_phenot | 0.88399462 |
| 129 | MP0000689_abnormal_spleen_morphology | 0.87962543 |
| 130 | MP0005645_abnormal_hypothalamus_physiol | 0.86661993 |
| 131 | MP0008874_decreased_physiological_sensi | 0.86540171 |
| 132 | MP0003690_abnormal_glial_cell | 0.86394278 |
| 133 | MP0001485_abnormal_pinna_reflex | 0.86185416 |
| 134 | MP0002102_abnormal_ear_morphology | 0.86045268 |
| 135 | MP0002249_abnormal_larynx_morphology | 0.85877830 |
| 136 | MP0001348_abnormal_lacrimal_gland | 0.85159306 |
| 137 | MP0003861_abnormal_nervous_system | 0.85051270 |
| 138 | MP0005164_abnormal_response_to | 0.84304551 |
| 139 | MP0004215_abnormal_myocardial_fiber | 0.84174823 |
| 140 | MP0006292_abnormal_olfactory_placode | 0.84077172 |
| 141 | MP0004133_heterotaxia | 0.83995835 |
| 142 | MP0002638_abnormal_pupillary_reflex | 0.83948205 |
| 143 | MP0005166_decreased_susceptibility_to | 0.83094867 |
| 144 | MP0003634_abnormal_glial_cell | 0.82701592 |
| 145 | MP0001544_abnormal_cardiovascular_syste | 0.82091958 |
| 146 | MP0005385_cardiovascular_system_phenoty | 0.82091958 |
| 147 | MP0002972_abnormal_cardiac_muscle | 0.81914535 |
| 148 | MP0008789_abnormal_olfactory_epithelium | 0.81864401 |
| 149 | MP0003121_genomic_imprinting | 0.79646628 |
| 150 | MP0003787_abnormal_imprinting | 0.78703501 |
| 151 | MP0002932_abnormal_joint_morphology | 0.78666611 |
| 152 | MP0001727_abnormal_embryo_implantation | 0.78243442 |
| 153 | MP0009765_abnormal_xenobiotic_induced | 0.78166513 |
| 154 | MP0001542_abnormal_bone_strength | 0.77827489 |
| 155 | MP0003755_abnormal_palate_morphology | 0.76956445 |
| 156 | MP0002127_abnormal_cardiovascular_syste | 0.76839375 |
| 157 | MP0003938_abnormal_ear_development | 0.76238739 |
| 158 | MP0002177_abnormal_outer_ear | 0.75749369 |
| 159 | MP0008004_abnormal_stomach_pH | 0.75237581 |
| 160 | MP0004510_myositis | 0.72213997 |
| 161 | MP0002722_abnormal_immune_system | 0.72105857 |
| 162 | MP0003567_abnormal_fetal_cardiomyocyte | 0.71975165 |
| 163 | MP0001943_abnormal_respiration | 0.71706779 |
| 164 | MP0002116_abnormal_craniofacial_bone | 0.71064003 |
| 165 | MP0003942_abnormal_urinary_system | 0.70857523 |
| 166 | MP0002332_abnormal_exercise_endurance | 0.70480528 |
| 167 | MP0002114_abnormal_axial_skeleton | 0.69660354 |
| 168 | MP0005330_cardiomyopathy | 0.69158948 |
| 169 | MP0002081_perinatal_lethality | 0.69018835 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 6.35536282 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.30123224 |
| 3 | Nemaline bodies (HP:0003798) | 6.13986234 |
| 4 | Exercise-induced myalgia (HP:0003738) | 5.48932378 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.16278639 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 4.57859025 |
| 7 | Calf muscle hypertrophy (HP:0008981) | 4.55214737 |
| 8 | Distal arthrogryposis (HP:0005684) | 4.33880716 |
| 9 | Round ear (HP:0100830) | 4.17252155 |
| 10 | Stomatitis (HP:0010280) | 4.16464324 |
| 11 | Difficulty running (HP:0009046) | 4.01980324 |
| 12 | Myopathic facies (HP:0002058) | 3.94864703 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 3.93790919 |
| 14 | Optic neuritis (HP:0100653) | 3.93790919 |
| 15 | Type 1 muscle fiber predominance (HP:0003803) | 3.90048344 |
| 16 | Recurrent bacterial skin infections (HP:0005406) | 3.78094976 |
| 17 | Orchitis (HP:0100796) | 3.70596820 |
| 18 | Myositis (HP:0100614) | 3.66520912 |
| 19 | EMG: myopathic abnormalities (HP:0003458) | 3.50378416 |
| 20 | Eczematoid dermatitis (HP:0000976) | 3.49266926 |
| 21 | Recurrent abscess formation (HP:0002722) | 3.41405357 |
| 22 | Focal motor seizures (HP:0011153) | 3.41359219 |
| 23 | Abnormality of the calf musculature (HP:0001430) | 3.38723446 |
| 24 | Muscle fiber splitting (HP:0003555) | 3.36803845 |
| 25 | Calcaneovalgus deformity (HP:0001848) | 3.35485980 |
| 26 | Abnormality of macrophages (HP:0004311) | 3.24169006 |
| 27 | Disinhibition (HP:0000734) | 3.22838421 |
| 28 | Myotonia (HP:0002486) | 3.20152988 |
| 29 | Ankle clonus (HP:0011448) | 3.15395361 |
| 30 | Absent phalangeal crease (HP:0006109) | 3.08038598 |
| 31 | Deformed tarsal bones (HP:0008119) | 3.07287436 |
| 32 | Amyotrophic lateral sclerosis (HP:0007354) | 3.05399499 |
| 33 | Broad-based gait (HP:0002136) | 3.04970604 |
| 34 | Shoulder girdle muscle weakness (HP:0003547) | 3.02482929 |
| 35 | Myokymia (HP:0002411) | 3.00688479 |
| 36 | Ulnar deviation of the wrist (HP:0003049) | 2.93621486 |
| 37 | Fetal akinesia sequence (HP:0001989) | 2.88257266 |
| 38 | Hyporeflexia of lower limbs (HP:0002600) | 2.86473223 |
| 39 | Keratoconjunctivitis sicca (HP:0001097) | 2.85121141 |
| 40 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.79416947 |
| 41 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.76438338 |
| 42 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.76438338 |
| 43 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.76132290 |
| 44 | Muscle stiffness (HP:0003552) | 2.70824536 |
| 45 | Keratoconjunctivitis (HP:0001096) | 2.68370435 |
| 46 | Neck muscle weakness (HP:0000467) | 2.65753409 |
| 47 | Abnormal finger flexion creases (HP:0006143) | 2.61882075 |
| 48 | Rhabdomyolysis (HP:0003201) | 2.60986647 |
| 49 | Malignant hyperthermia (HP:0002047) | 2.60966541 |
| 50 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.60730370 |
| 51 | Cortical dysplasia (HP:0002539) | 2.55336541 |
| 52 | Mediastinal lymphadenopathy (HP:0100721) | 2.55158589 |
| 53 | Encephalitis (HP:0002383) | 2.53040238 |
| 54 | Pelvic girdle muscle weakness (HP:0003749) | 2.52835939 |
| 55 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.51824506 |
| 56 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.43885851 |
| 57 | Subaortic stenosis (HP:0001682) | 2.43885851 |
| 58 | Spontaneous hematomas (HP:0007420) | 2.40441148 |
| 59 | Spastic gait (HP:0002064) | 2.38748925 |
| 60 | Increased variability in muscle fiber diameter (HP:0003557) | 2.38571084 |
| 61 | Agnosia (HP:0010524) | 2.36930072 |
| 62 | Rimmed vacuoles (HP:0003805) | 2.35460246 |
| 63 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.32683017 |
| 64 | Nonprogressive disorder (HP:0003680) | 2.31586101 |
| 65 | Polyphagia (HP:0002591) | 2.31513773 |
| 66 | Inappropriate behavior (HP:0000719) | 2.30847025 |
| 67 | Urticaria (HP:0001025) | 2.29760486 |
| 68 | Supranuclear gaze palsy (HP:0000605) | 2.26891513 |
| 69 | Urinary urgency (HP:0000012) | 2.25402167 |
| 70 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.22023246 |
| 71 | Chest pain (HP:0100749) | 2.18351801 |
| 72 | Myoglobinuria (HP:0002913) | 2.15920645 |
| 73 | EMG: neuropathic changes (HP:0003445) | 2.13556586 |
| 74 | Gastrointestinal infarctions (HP:0005244) | 2.12179963 |
| 75 | Gowers sign (HP:0003391) | 2.12167775 |
| 76 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.10883639 |
| 77 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.10883639 |
| 78 | Episodic fever (HP:0001954) | 2.09355214 |
| 79 | Loss of speech (HP:0002371) | 2.08599433 |
| 80 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.05905723 |
| 81 | Sudden death (HP:0001699) | 2.04001603 |
| 82 | Abnormality of the corticospinal tract (HP:0002492) | 2.02837467 |
| 83 | Focal seizures (HP:0007359) | 2.02035680 |
| 84 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.00985062 |
| 85 | Limb-girdle muscle weakness (HP:0003325) | 2.00023629 |
| 86 | Epileptic encephalopathy (HP:0200134) | 1.98426837 |
| 87 | Akinesia (HP:0002304) | 1.97677625 |
| 88 | Lower limb muscle weakness (HP:0007340) | 1.97288172 |
| 89 | Peripheral hypomyelination (HP:0007182) | 1.96493051 |
| 90 | Obstructive lung disease (HP:0006536) | 1.95923298 |
| 91 | Chronic obstructive pulmonary disease (HP:0006510) | 1.95923298 |
| 92 | Limb-girdle muscle atrophy (HP:0003797) | 1.94987151 |
| 93 | Hematochezia (HP:0002573) | 1.94119782 |
| 94 | Anorexia (HP:0002039) | 1.93372843 |
| 95 | Limb dystonia (HP:0002451) | 1.92480026 |
| 96 | Increased IgM level (HP:0003496) | 1.92199066 |
| 97 | Nasal speech (HP:0001611) | 1.91302012 |
| 98 | Alacrima (HP:0000522) | 1.89534568 |
| 99 | Cerebral hypomyelination (HP:0006808) | 1.88389420 |
| 100 | Recurrent skin infections (HP:0001581) | 1.87456377 |
| 101 | Bowel incontinence (HP:0002607) | 1.86922115 |
| 102 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.85121192 |
| 103 | Hypoplasia of the brainstem (HP:0002365) | 1.85121192 |
| 104 | Abnormality of the endocardium (HP:0004306) | 1.84972318 |
| 105 | Progressive inability to walk (HP:0002505) | 1.84635385 |
| 106 | Abnormality of the foot musculature (HP:0001436) | 1.84130171 |
| 107 | Mutism (HP:0002300) | 1.83884054 |
| 108 | Weak cry (HP:0001612) | 1.83591315 |
| 109 | Hypochromic microcytic anemia (HP:0004840) | 1.83581425 |
| 110 | Leukocytosis (HP:0001974) | 1.83174732 |
| 111 | Proximal amyotrophy (HP:0007126) | 1.82479775 |
| 112 | Polycythemia (HP:0001901) | 1.82436454 |
| 113 | Atonic seizures (HP:0010819) | 1.81098802 |
| 114 | Amyloidosis (HP:0011034) | 1.80180952 |
| 115 | Foot dorsiflexor weakness (HP:0009027) | 1.79831756 |
| 116 | Polyneuropathy (HP:0001271) | 1.78739857 |
| 117 | Frequent falls (HP:0002359) | 1.76417946 |
| 118 | Exertional dyspnea (HP:0002875) | 1.75950746 |
| 119 | Insidious onset (HP:0003587) | 1.75399447 |
| 120 | Termporal pattern (HP:0011008) | 1.75399447 |
| 121 | Asymmetric septal hypertrophy (HP:0001670) | 1.74275219 |
| 122 | Difficulty climbing stairs (HP:0003551) | 1.74264134 |
| 123 | Lipid accumulation in hepatocytes (HP:0006561) | 1.72073020 |
| 124 | Increased intramyocellular lipid droplets (HP:0012240) | 1.71992170 |
| 125 | Areflexia of lower limbs (HP:0002522) | 1.71959096 |
| 126 | Obstructive sleep apnea (HP:0002870) | 1.71139327 |
| 127 | Scapular winging (HP:0003691) | 1.71042282 |
| 128 | Abnormal large intestine physiology (HP:0012700) | 1.69494616 |
| 129 | Hemoptysis (HP:0002105) | 1.68187655 |
| 130 | Increased hepatocellular lipid droplets (HP:0006565) | 1.67604550 |
| 131 | Lissencephaly (HP:0001339) | 1.67551222 |
| 132 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.67255218 |
| 133 | Recurrent fungal infections (HP:0002841) | 1.65838610 |
| 134 | Diminished motivation (HP:0000745) | 1.65441393 |
| 135 | T lymphocytopenia (HP:0005403) | 1.65293374 |
| 136 | Agitation (HP:0000713) | 1.64015189 |
| 137 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.64014032 |
| 138 | Abnormality of alanine metabolism (HP:0010916) | 1.64014032 |
| 139 | Hyperalaninemia (HP:0003348) | 1.64014032 |
| 140 | Stridor (HP:0010307) | 1.63530157 |
| 141 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.63118960 |
| 142 | Megalencephaly (HP:0001355) | 1.62348602 |
| 143 | Poor eye contact (HP:0000817) | 1.62343448 |
| 144 | Lower limb amyotrophy (HP:0007210) | 1.62281800 |
| 145 | Pheochromocytoma (HP:0002666) | 1.61461448 |
| 146 | Gait imbalance (HP:0002141) | 1.61211543 |
| 147 | Ulnar deviation of finger (HP:0009465) | 1.60061100 |
| 148 | Gangrene (HP:0100758) | 1.59816212 |
| 149 | Dysmetria (HP:0001310) | 1.59691864 |
| 150 | Retinal dysplasia (HP:0007973) | 1.59628367 |
| 151 | Vasculitis (HP:0002633) | 1.59613985 |
| 152 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.59469091 |
| 153 | Poor speech (HP:0002465) | 1.59397149 |
| 154 | Bulbar palsy (HP:0001283) | 1.58855604 |
| 155 | Congenital primary aphakia (HP:0007707) | 1.58575267 |
| 156 | Abnormality of the calcaneus (HP:0008364) | 1.58573770 |
| 157 | Visual hallucinations (HP:0002367) | 1.58335366 |
| 158 | Increased muscle lipid content (HP:0009058) | 1.57797751 |
| 159 | Hyperkalemia (HP:0002153) | 1.56714326 |
| 160 | Decreased lacrimation (HP:0000633) | 1.56353290 |
| 161 | Abnormality of the neuromuscular junction (HP:0003398) | 1.55962870 |
| 162 | Fatigable weakness (HP:0003473) | 1.55962870 |
| 163 | Adducted thumb (HP:0001181) | 1.55686085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 4.31615539 |
| 2 | PHKG2 | 4.12230567 |
| 3 | PHKG1 | 4.12230567 |
| 4 | LIMK1 | 3.04843560 |
| 5 | OBSCN | 2.95160222 |
| 6 | DYRK3 | 2.92839417 |
| 7 | CASK | 2.70215293 |
| 8 | TRIM28 | 2.44415764 |
| 9 | MAP3K6 | 2.39851638 |
| 10 | UHMK1 | 2.16861705 |
| 11 | CDK19 | 2.14585735 |
| 12 | MAP2K3 | 2.07627619 |
| 13 | TTN | 2.05975041 |
| 14 | EPHA3 | 2.04705216 |
| 15 | KSR1 | 2.02777553 |
| 16 | DYRK2 | 1.97956164 |
| 17 | BLK | 1.94911427 |
| 18 | NTRK3 | 1.94865573 |
| 19 | IRAK4 | 1.90142382 |
| 20 | SIK3 | 1.84629701 |
| 21 | NME1 | 1.83012850 |
| 22 | MAP3K5 | 1.76989281 |
| 23 | MAP3K9 | 1.71340195 |
| 24 | EPHA4 | 1.70455890 |
| 25 | TAOK1 | 1.68851897 |
| 26 | DMPK | 1.68739276 |
| 27 | RIPK4 | 1.67476173 |
| 28 | DYRK1B | 1.66002449 |
| 29 | PAK6 | 1.64123010 |
| 30 | NTRK2 | 1.62052333 |
| 31 | PRPF4B | 1.61494003 |
| 32 | MINK1 | 1.57780175 |
| 33 | MATK | 1.52295054 |
| 34 | CSK | 1.51345773 |
| 35 | PKN1 | 1.50825793 |
| 36 | ERBB3 | 1.50232140 |
| 37 | BCR | 1.49688570 |
| 38 | MAPK13 | 1.46077458 |
| 39 | RPS6KA4 | 1.44220194 |
| 40 | MAP3K12 | 1.42786012 |
| 41 | TAOK3 | 1.42542421 |
| 42 | MAP3K4 | 1.41215820 |
| 43 | TYK2 | 1.38960152 |
| 44 | CSNK1A1L | 1.35454599 |
| 45 | BCKDK | 1.33685248 |
| 46 | CSNK1G3 | 1.32334811 |
| 47 | GRK7 | 1.31032592 |
| 48 | OXSR1 | 1.29801783 |
| 49 | CSNK1G2 | 1.24966266 |
| 50 | EPHB1 | 1.23120908 |
| 51 | TNIK | 1.13800267 |
| 52 | MAP2K7 | 1.12832210 |
| 53 | STK39 | 1.12569845 |
| 54 | IRAK2 | 1.08962803 |
| 55 | FGFR2 | 1.08901763 |
| 56 | CDK5 | 1.08168226 |
| 57 | MARK2 | 1.07285838 |
| 58 | EPHB2 | 1.06094710 |
| 59 | BMPR2 | 1.05821558 |
| 60 | SRPK1 | 1.04570715 |
| 61 | TXK | 1.04204241 |
| 62 | BMPR1B | 1.02190220 |
| 63 | PINK1 | 1.01511250 |
| 64 | MAP2K4 | 1.01400389 |
| 65 | ICK | 0.99131618 |
| 66 | LATS2 | 0.97271573 |
| 67 | MUSK | 0.97060034 |
| 68 | CAMK2B | 0.97036951 |
| 69 | CDK14 | 0.96544806 |
| 70 | MAP3K14 | 0.96345096 |
| 71 | CSNK1G1 | 0.94563049 |
| 72 | MAP4K2 | 0.94483186 |
| 73 | ROCK2 | 0.93576964 |
| 74 | IKBKE | 0.90063764 |
| 75 | ZAP70 | 0.89202658 |
| 76 | WNK1 | 0.88743913 |
| 77 | SGK494 | 0.87874139 |
| 78 | SGK223 | 0.87874139 |
| 79 | ADRBK2 | 0.87359801 |
| 80 | MAPK12 | 0.86996012 |
| 81 | MAPK7 | 0.86693788 |
| 82 | SIK2 | 0.85535423 |
| 83 | CDK18 | 0.84374719 |
| 84 | NEK6 | 0.83762136 |
| 85 | KSR2 | 0.83194996 |
| 86 | MAP3K11 | 0.83194830 |
| 87 | PAK3 | 0.82064916 |
| 88 | JAK2 | 0.81908949 |
| 89 | HCK | 0.81537025 |
| 90 | CAMKK2 | 0.80120886 |
| 91 | LYN | 0.78540620 |
| 92 | TBK1 | 0.78487090 |
| 93 | WNK3 | 0.77985463 |
| 94 | CAMK2G | 0.77768482 |
| 95 | MAP3K3 | 0.77408226 |
| 96 | TYRO3 | 0.77213014 |
| 97 | CDK15 | 0.76391041 |
| 98 | CAMK4 | 0.76202060 |
| 99 | SYK | 0.72969745 |
| 100 | MAP3K1 | 0.72733710 |
| 101 | MAP4K1 | 0.72204632 |
| 102 | MAP3K7 | 0.70546016 |
| 103 | PBK | 0.70044945 |
| 104 | CAMK2A | 0.69970274 |
| 105 | CDK11A | 0.68582179 |
| 106 | ILK | 0.67946597 |
| 107 | PIK3CA | 0.67048059 |
| 108 | CAMK2D | 0.66493426 |
| 109 | DAPK2 | 0.58724399 |
| 110 | PRKD1 | 0.58121409 |
| 111 | RAF1 | 0.57717146 |
| 112 | TAOK2 | 0.57263904 |
| 113 | PIK3CG | 0.57155093 |
| 114 | ACVR1B | 0.55245378 |
| 115 | SGK1 | 0.55056705 |
| 116 | MARK3 | 0.54863085 |
| 117 | TESK2 | 0.54739456 |
| 118 | JAK3 | 0.54009819 |
| 119 | PNCK | 0.52365214 |
| 120 | DDR2 | 0.49445673 |
| 121 | ARAF | 0.49205756 |
| 122 | BTK | 0.48938935 |
| 123 | YES1 | 0.46123561 |
| 124 | LCK | 0.45623571 |
| 125 | EGFR | 0.44581431 |
| 126 | MKNK2 | 0.44216194 |
| 127 | PRKCE | 0.44211278 |
| 128 | PLK2 | 0.44032813 |
| 129 | TNK2 | 0.43888844 |
| 130 | FYN | 0.43640445 |
| 131 | ROCK1 | 0.43358141 |
| 132 | HIPK2 | 0.41932455 |
| 133 | DYRK1A | 0.40966201 |
| 134 | PRKG1 | 0.39832510 |
| 135 | FGR | 0.38984235 |
| 136 | PIM2 | 0.38129792 |
| 137 | NEK1 | 0.37972828 |
| 138 | STK11 | 0.37835395 |
| 139 | IRAK1 | 0.37812835 |
| 140 | MKNK1 | 0.37386476 |
| 141 | PLK4 | 0.37206458 |
| 142 | TESK1 | 0.36644632 |
| 143 | MAPK10 | 0.34723341 |
| 144 | MAP2K6 | 0.32007235 |
| 145 | PRKCG | 0.29681883 |
| 146 | DAPK3 | 0.29679987 |
| 147 | FES | 0.29331695 |
| 148 | FGFR1 | 0.28946660 |
| 149 | CAMK1 | 0.28826182 |
| 150 | CDC42BPA | 0.28623539 |
| 151 | CCNB1 | 0.27721823 |
| 152 | MAPK9 | 0.27422440 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Legionellosis_Homo sapiens_hsa05134 | 2.88748802 |
| 2 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.70260463 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.68543448 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.63723188 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.43124846 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.35350743 |
| 7 | Tuberculosis_Homo sapiens_hsa05152 | 2.34662610 |
| 8 | Axon guidance_Homo sapiens_hsa04360 | 2.27068218 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.26513618 |
| 10 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.95310339 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 1.89993038 |
| 12 | Nicotine addiction_Homo sapiens_hsa05033 | 1.88753115 |
| 13 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.79149153 |
| 14 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.78605758 |
| 15 | Morphine addiction_Homo sapiens_hsa05032 | 1.77340427 |
| 16 | GABAergic synapse_Homo sapiens_hsa04727 | 1.76959020 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.73571479 |
| 18 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.73319708 |
| 19 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.72555402 |
| 20 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.71882725 |
| 21 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.71857781 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.70952088 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.70943513 |
| 24 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.68546604 |
| 25 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.67303158 |
| 26 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.66379564 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.62737166 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.62516779 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.56631585 |
| 30 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.54725338 |
| 31 | Long-term potentiation_Homo sapiens_hsa04720 | 1.53679674 |
| 32 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.52299084 |
| 33 | Long-term depression_Homo sapiens_hsa04730 | 1.50876429 |
| 34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.50790202 |
| 35 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.43234716 |
| 36 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.42618917 |
| 37 | Olfactory transduction_Homo sapiens_hsa04740 | 1.42565278 |
| 38 | Cocaine addiction_Homo sapiens_hsa05030 | 1.30223715 |
| 39 | Gap junction_Homo sapiens_hsa04540 | 1.29811769 |
| 40 | Protein export_Homo sapiens_hsa03060 | 1.28107079 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28022908 |
| 42 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.25211573 |
| 43 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.22874505 |
| 44 | Asthma_Homo sapiens_hsa05310 | 1.22435223 |
| 45 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.21896781 |
| 46 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.21462496 |
| 47 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.21435057 |
| 48 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.20919051 |
| 49 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.20667253 |
| 50 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.20025466 |
| 51 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.19874795 |
| 52 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.19763860 |
| 53 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.17485720 |
| 54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.14493831 |
| 55 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.14434410 |
| 56 | Circadian rhythm_Homo sapiens_hsa04710 | 1.13834224 |
| 57 | Renin secretion_Homo sapiens_hsa04924 | 1.12762647 |
| 58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.12372261 |
| 59 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.12011417 |
| 60 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.12003412 |
| 61 | Melanogenesis_Homo sapiens_hsa04916 | 1.11529728 |
| 62 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.10687646 |
| 63 | Influenza A_Homo sapiens_hsa05164 | 1.09652154 |
| 64 | Measles_Homo sapiens_hsa05162 | 1.09433527 |
| 65 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08191870 |
| 66 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.06880552 |
| 67 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.06028655 |
| 68 | Colorectal cancer_Homo sapiens_hsa05210 | 1.05691535 |
| 69 | Insulin secretion_Homo sapiens_hsa04911 | 1.05301499 |
| 70 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01467573 |
| 71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.01259161 |
| 72 | Tight junction_Homo sapiens_hsa04530 | 1.01066238 |
| 73 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.00691302 |
| 74 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.99568162 |
| 75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.96285511 |
| 76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.95743933 |
| 77 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.95438897 |
| 78 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.94919187 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.94306690 |
| 80 | Salmonella infection_Homo sapiens_hsa05132 | 0.94123880 |
| 81 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.93934942 |
| 82 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.93137625 |
| 83 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.92270951 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.92107433 |
| 85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.91995929 |
| 86 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.91544444 |
| 87 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.90094061 |
| 88 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.90000556 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.89069221 |
| 90 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88400044 |
| 91 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.88158320 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.87138442 |
| 93 | Salivary secretion_Homo sapiens_hsa04970 | 0.86488755 |
| 94 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.86436355 |
| 95 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.86119846 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85466943 |
| 97 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.84544900 |
| 98 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.83412150 |
| 99 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.83320442 |
| 100 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.83166312 |
| 101 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.82524396 |
| 102 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.80263841 |
| 103 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79970772 |
| 104 | Hepatitis B_Homo sapiens_hsa05161 | 0.78930988 |
| 105 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.78864641 |
| 106 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.78044116 |
| 107 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77957392 |
| 108 | Parkinsons disease_Homo sapiens_hsa05012 | 0.77909452 |
| 109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.77882324 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.77448091 |
| 111 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.76646346 |
| 112 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76441397 |
| 113 | Glioma_Homo sapiens_hsa05214 | 0.76414279 |
| 114 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.76075339 |
| 115 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.75852053 |
| 116 | Shigellosis_Homo sapiens_hsa05131 | 0.75702868 |
| 117 | Taste transduction_Homo sapiens_hsa04742 | 0.75182267 |
| 118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74760836 |
| 119 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.74601590 |
| 120 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73522192 |
| 121 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72655184 |
| 122 | Alzheimers disease_Homo sapiens_hsa05010 | 0.71875109 |
| 123 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.71635777 |
| 124 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71230394 |
| 125 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.70452900 |
| 126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.70025871 |
| 127 | Lysosome_Homo sapiens_hsa04142 | 0.69573309 |
| 128 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65413746 |
| 129 | Huntingtons disease_Homo sapiens_hsa05016 | 0.63751682 |
| 130 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62018976 |
| 131 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61220408 |
| 132 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59997982 |
| 133 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58958247 |
| 134 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.58677113 |
| 135 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.57903580 |
| 136 | Adherens junction_Homo sapiens_hsa04520 | 0.56819843 |
| 137 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56671138 |
| 138 | Phagosome_Homo sapiens_hsa04145 | 0.56584144 |
| 139 | Focal adhesion_Homo sapiens_hsa04510 | 0.56412764 |
| 140 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.56308266 |
| 141 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.56271596 |
| 142 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56121467 |
| 143 | Melanoma_Homo sapiens_hsa05218 | 0.55937740 |
| 144 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.55578616 |
| 145 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55442971 |
| 146 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54609923 |
| 147 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52577314 |
| 148 | Hepatitis C_Homo sapiens_hsa05160 | 0.52134541 |
| 149 | Platelet activation_Homo sapiens_hsa04611 | 0.51677538 |
| 150 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50863872 |
| 151 | RNA degradation_Homo sapiens_hsa03018 | 0.48249274 |
| 152 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.45242567 |
| 153 | Peroxisome_Homo sapiens_hsa04146 | 0.44080634 |
| 154 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.43520162 |
| 155 | * Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.43195260 |
| 156 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42261862 |
| 157 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40677061 |
| 158 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.40522756 |
| 159 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.40132860 |
| 160 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.40084573 |
| 161 | Apoptosis_Homo sapiens_hsa04210 | 0.32554242 |
| 162 | Phototransduction_Homo sapiens_hsa04744 | 0.31503494 |

